The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

U.S. prosecutors are looking into a claim that GSK (GSK) scientist, who formerly worked at Pfizer (PFE), told colleagues that Pfizer delayed announcing the success of its Covid vaccine in 2020 until ...

Shares of Pfizer Inc. PFE slipped 1.33% to $25.21 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.12% to 5,712.20 and Dow ...

Tuesday’s total option volume of 43.6 million contracts resulted in net open interest growth of 5.66 million calls and 4.59 million puts.

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...

LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...